|
Brussels, |
|
EU Medical Devices & In Vitro Diagnostics
MDR, IVDR and the changing European regulatory framework
MEDEV · Medical Devices · In Vitro Diagnostics · EU Regulation
Preview · Selected content from the full eBriefing
EU medical-device regulation is changing, but existing obligations continue to apply. Manufacturers, importers, distributors and healthcare organisations need to know which rules apply now, which deadlines depend on transition conditions and which reforms remain proposals.
This updated eBriefing brings together the MDR and IVDR framework, legacy-device transitions, EUDAMED, evidence and surveillance requirements, supply-interruption duties and the EU’s targeted simplification initiative.
What the full eBriefing helps you understand
- Current requirements: the responsibilities of manufacturers, authorised representatives, importers and distributors.
- Transition deadlines: the MDR 2027–2028 and IVDR 2027–2029 dates, with the earlier eligibility milestones.
- EUDAMED: mandatory modules and relevant November 2026 registration cases.
- Regulatory changes: adopted measures, staged application dates and the pending MDR/IVDR revision.
- Practical priorities: evidence, notified-body arrangements, supply continuity and a portfolio action plan.
A first look at the analysis
Compliance and reform are running in parallel
The immediate planning question is whether each product can remain lawfully available while certification, evidence and registration work continue. The expiry date printed on a legacy certificate is only part of that assessment: the applicable transition conditions and the manufacturer’s documented milestones also matter.
EUDAMED adds a near-term operational task. Four modules have been mandatory since 28 May 2026, while relevant existing-device cases have a registration milestone on 28 November 2026. Device, operator and certificate data need to be checked together.
The wider simplification proposal, COM(2025)1023, remains under examination. At the edition cutoff, Parliament’s Legislative Observatory records the procedure as awaiting committee decision. Proposed certification changes should therefore be monitored without postponing current obligations.
Read the complete MEDEV eBriefing
Access all 15 chapters, the transition tables, EUDAMED milestones, practical action plan and official sources.
Read the Full eBriefing →Full edition available to readers with the relevant eEuropa access.
Official sources: Commission: medical devices regulatory overview · MDR transition — Regulation (EU) 2023/607 · IVDR transition, EUDAMED and supply — Regulation (EU) 2024/1860 · Commission: EUDAMED rollout and module status · European Parliament: 2025/0404(COD), procedure and documents.
Edition note: based on the eEuropa Medical Devices PDF last updated on 2 December 2024, substantively revised for the web edition of 28 October 2026. Full references, operational qualifications and abbreviations are included in the complete edition.
© 2026 eEuropa. All rights reserved. Prepared by eEuropa Belgium · Your Gate to Europe.